Velan Capital Investment Management LP
Position in PYXS — Pyxis Oncology, Inc.
CIK 1848809
ALPHARETTA, GA
Position in PYXS
as of Dec 31, 2025
· filed Feb 13, 2026
Position Value
$46,000
-$76,100 QoQ
Shares Held
40,000
-27.3% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Velan Capital Investment Management LP holds $144,698,271 across 42 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
100,781 | $32,470,630 | |
| 2 | TARA |
Protara Therapeutics, Inc.
|
2,834,652 | $14,768,536 | |
| 3 | STRO |
Sutro Biopharma, Inc.
|
512,160 | $12,757,905 | |
| 4 | EVMN |
Evommune, Inc.
|
446,255 | $10,259,402 | |
| 5 | MPLT |
MapLight Therapeutics, Inc.
|
492,893 | $10,020,514 | |
| 6 | TENX |
Tenax Therapeutics, Inc.
|
583,333 | $9,327,494 | |
| 7 | ABVX |
Abivax S.A.
|
77,000 | $8,573,950 | |
| 8 | HRTX |
Heron Therapeutics, Inc. /De/
|
8,753,290 | $7,002,632 |
All Filings in PYXS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $46,000 | 40,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $122,100 | 55,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $44,000 | 40,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||